Orphan Drug Status and the New Regulations on Medicare

One of our long-term favorites bio marin pharmaceutical specializes in what are known as orphan drugs treatments for rare diseases i think this immunizes them against some of these medical compounds remember the rules that governments are trying to do to keep prices down. New hematly a drug has been approved in europe and submitted to the fda for approval here in the united states don't take it from me though let's check in with jj b anime he's the chairman co environment pharmaceutical to get a better sense of where his company is coming from mr bander may welcome back to mad money thank you jim always a pleasure to be here okay so jj before we go away since it